Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Aldeyra Therapeutics, Inc. | d519779dex321.htm |
EX-31.2 - EX-31.2 - Aldeyra Therapeutics, Inc. | d519779dex312.htm |
EX-31.1 - EX-31.1 - Aldeyra Therapeutics, Inc. | d519779dex311.htm |
EX-10.28 - EX-10.28 - Aldeyra Therapeutics, Inc. | d519779dex1028.htm |
10-K - 10-K - Aldeyra Therapeutics, Inc. | d519779d10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Aldeyra Therapeutics, Inc.
Lexington, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-206539) and Form S-8 (Nos. 333-196674, 333-203076, 333-210492, 333-213045 and 333-217043) of Aldeyra Therapeutics, Inc. of our report dated March 29, 2018, relating to the financial statements of Aldeyra Therapeutics, Inc., which appears in this Annual Report on Form 10-K for the year ended December 31, 2017.
/s/ BDO USA, LLP
Boston, Massachusetts
March 29, 2018